Digest Network Come funziona
Network
/
Società
ST
Non verificato

STORM Therapeutics

Di cosa scriviamo

BiologiaFarmaceuticaFinanzaSanitàTelecomunicazioni

3 comunicati stampa

Guarda tutti i comunicati
27/05/2025
Farmaceutica
Information Technology
Telecomunicazioni
Sanità
Biologia
STORM Therapeutics Announces First Patient Dosed in Clinical Collaboration to Evaluate STC-15 in Combination with LOQTORZI® and Appointment of Atif Abbas, M.D., as Chief Medical Officer
Fonte
STORM Therapeutics
Emittente
PR News Wire
1.00
0
11/11/2024
Farmaceutica
Sanità
Finanza
Biologia
STORM Therapeutics Presents New Clinical Data on its First-in-Class METTL3 Inhibitor STC-15 at SITC 2024
Fonte
STORM Therapeutics
Emittente
PR News Wire
1.00
0
17/06/2024
Farmaceutica
Sanità
Società
Biologia
Tony Kouzarides, Founder of STORM Therapeutics, Awarded British Knighthood for Services to Healthcare Innovation and Delivery
Fonte
STORM Therapeutics
Emittente
PR News Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0